Financials

News Discussions Technicals Seasonals

950220 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

NeoImmuneTech, Inc. is a clinical-stage biopharmaceutical company. which engages in the development of T cell-centered novel immunotherapeutics. The firm develops its product NT-I7 for the treatment of lymphopenia. The company was founded by Se Hwan Yang in January 2014 and is headquartered in Rockville, MD.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

950220 does not pay dividends

The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company